CoChat

Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors

Jafari, Behzad, Pourseif, Mohammad M., Barar, Jaleh, Rafi, Mohammad A., Omidi, Yadollah · 2019 · Expert Opinion on Drug Delivery
Cited by 65

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Introduction: Transportation of the nutrients and other substances from the blood to the brain is selectively controlled by the brain capillary endothelial cells that form a restrictive barrier, so-called blood-brain barrier (BBB). Currently, there is no unimpeachable approach to overcome the BBB obstructiveness because the existing options are either invasive or ineffective.Areas covered: This review delineates the biological impacts of BBB on brain drug delivery and targeting. The nanoscaled multifunctional shuttles armed with the targeting entities (e.g., antibodies and peptides) are discussed. Important insights are remarked into the combinatorial screening methodologies used for the identification of de novo peptides capable of crossing BBB and targeting the brain.Expert opinion: Depending on the physicochemical properties of small molecules and macromolecules, they may cross the BBB and get into the brain either through passive diffusion or active/facilitated transportation and transcytosis in a very selectively controlled manner. Phage-derived shuttle peptides can specifically be selected against BBB endocytic machinery and used in engineering novel peptide-drug conjugates (PDCs). Nanoscaled multitargeting delivery systems encompassing PDCs can overcome the BBB obstructiveness and deliver drugs specifically to diseased cells in the brain with trivial side effects.Trial registration: ClinicalTrials.gov identifier: NCT02048059.Trial registration: ClinicalTrials.gov identifier: NCT01767155.Trial registration: ClinicalTrials.gov identifier: NCT01234519.Trial registration: ClinicalTrials.gov identifier: NCT00569257.Trial registration: ClinicalTrials.gov identifier: NCT01240629.Trial registration: ClinicalTrials.gov identifier: NCT0169828.Trial registration: ClinicalTrials.gov identifier: NCT01480583.Trial registration: ClinicalTrials.gov identifier: NCT03613181.Trial registration: ClinicalTrials.gov identifier: NCT01967810.Trial registration: ClinicalTrials.gov identifier: NCT00539383.Trial registration: ClinicalTrials.gov identifier: NCT01098266.Trial registration: ClinicalTrials.gov identifier: NCT00576225.Trial registration: ClinicalTrials.gov identifier: NCT00148707.Trial registration: ClinicalTrials.gov identifier: NCT00017017.Trial registration: ClinicalTrials.gov identifier: NCT00270907.Trial registration: ClinicalTrials.gov identifier: NCT0005421.Trial registration: ClinicalTrials.gov identifier: NCT0006990.Trial registration: ClinicalTrials.gov identifier: NCT00054197.Trial registration: ClinicalTrials.gov identifier: NCT00763750.Trial registration: ClinicalTrials.gov identifier: NCT00060359.Trial registration: ClinicalTrials.gov identifier: NCT00265733.Trial registration: ClinicalTrials.gov identifier: NCT00045682.Trial registration: ClinicalTrials.gov identifier: NCT00108745.Trial registration: ClinicalTrials.gov identifier: NCT0148584.Trial registration: ClinicalTrials.gov identifier: NCT01577654.Trial registration: ClinicalTrials.gov identifier: NCT00722592.Trial registration: ClinicalTrials.gov identifier: NCT00507741.Trial registration: ClinicalTrials.gov identifier: NCT01170650.Trial registration: ClinicalTrials.gov identifier: NCT00308269.Trial registration: ClinicalTrials.gov identifier: NCT00511485.Trial registration: ClinicalTrials.gov identifier: NCT01002924.Trial registration: ClinicalTrials.gov identifier: NCT02607553.Trial registration: ClinicalTrials.gov identifier: NCT02067156.Trial registration: ClinicalTrials.gov identifier: NCT01734681.Trial registration: ClinicalTrials.gov identifier: NCT01056029.Trial registration: ClinicalTrials.gov identifier: NCT01777594.Trial registration: ClinicalTrials.gov identifier: NCT03386942.Trial registration: ClinicalTrials.gov identifier: NCT01386580.Trial registration: ClinicalTrials.gov identifier: NCT01818713.Trial registration: ClinicalTrials.gov identifier: NCT02048358.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/17425247.2019.1614911

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 65

Metadata

Authors
Jafari, B., Pourseif, M. M., Barar, J., Rafi, M. A., & Omidi, Y.
Venue
Expert Opinion on Drug Delivery
Published
2019-05-20
Volume
16
Issue
6
Pages
583-605
ISSN
  • 1742-5247 (ISSN-L)
  • 1744-7593
OpenAlex
W2945961248
Cited by
65
References
24
FWCI
3.33
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors. https://app.cochat.ai/papers/10.1080/17425247.2019.1614911
The paper
Jafari, B., Pourseif, M. M., Barar, J., Rafi, M. A., & Omidi, Y. (2019). Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors. Expert Opinion on Drug Delivery. https://doi.org/10.1080/17425247.2019.1614911

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.